Tg(LCAT)A31Ssf
Transgene Detail
|
Symbol: |
Tg(LCAT)A31Ssf |
Name: |
transgene insertion A31, Silvia Santamarina-Fojo |
MGI ID: |
MGI:3696854 |
Synonyms: |
hLCAT-tg subline A31 (U line hemizygous 120 copy), line T3 |
Transgene: |
Tg(LCAT)A31Ssf Location: unknown
|
Alliance: |
Tg(LCAT)A31Ssf page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(LCAT)A31Ssf expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
LCAT (3931) |
|
|
|
|
|
Mutation details: The transgene is a 6.2 kb human genomic DNA fragment containing the entire lecithin-cholesterol acyltransferase (LCAT) gene plus 851 bp of 5' and 1,134 bp of 3' flanking sequence. Based on Southern blot analysis, hemizygous mice of this founder line harbor 120 transgene copies. The plasma level of LCAT in mice with this transgene is 109-fold that of endogenous LCAT in non-transgenic mice. Northern blot analysis of various tissues from transgenic mice demonstrates expression of LCAT primarily in the liver, with much weaker expression in testis, brain, heart and lung.
(J:118356)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:118356 Vaisman BL, et al., Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem. 1995 May 19;270(20):12269-75 |
All: |
3 reference(s) |
|